The Gates Medical Research Institute (Gates MRI) has signed a landmark agreement with the Serum Institute of India Private Limited (SII) to manufacture M72/AS01E, a promising tuberculosis (TB) vaccine candidate currently undergoing Phase 3 clinical trials. more